TP53 and Li-Fraumeni syndrome: Germline TP53 PVs are associated with a wide range of cancers, known collectively as LFS, which is characterised by a predisposition towards a broad spectrum of malignancy, including soft-tissue sarcomas, adrenocortical carcinomas, brain tumours, early-onset BC and leukaemias [11].